AllJournalThesisConferenceNewspaperPatentStandardYear BookBook|ResearcherProject
all languages  Chinese Only  Other Languages
Author:E. Waldmann
Data Source:[J].Oud Holland, 1907, Vol.25 (1), pp.204 -210Brill Press
Author:E. Waldmann , R.G. Stark ...
Data Source:[J].Atherosclerosis(IF 3.706), 2015, Vol.241 (1), pp.e101-e102Elsevier
Author:E. Waldmann , H.V. Olesen ...
Data Source:[J].Journal of Cystic Fibrosis(IF 2.873), 2015, Vol.14, pp.S21-S21Elsevier
Abstract:Objectives(#br)To assess the relative impact of Pseudomonas aeruginosa , Burkholderia cepacia complex, Achromobacter xylosoxidans, Stenotrophomonas maltophilia, Mycobacterium abscessus complex (MABSC) and Mycobacterium avium complex (MAC) on longitudinal rate of decline in l...
Author:E. Waldmann , H.V. Olesen ...
Data Source:[J].Journal of Cystic Fibrosis(IF 2.873), 2015, Vol.14, pp.S54-S54Elsevier
Abstract:Objectives(#br)To assess the effect of Mycobacterium abscessus complex (MABSC) infection on lung function (%FEV1) in Danish CF patients.(#br)Methods(#br)A longitudinal analysis of %FEV1 trajectory was performed on all Danish patients born after 1974 using a linear mixed effe...
Author:E. Waldmann , K.G. Parhofer
Data Source:[J].Atherosclerosis (Supplements) (Component)(IF 4.333), 2015, Vol.18, pp.180-186Elsevier
Abstract:Abstract(#br)Background(#br)PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) increases LDL cholesterol (LDL-C) levels by stimulating the degradation of Low Density Lipoprotein receptors (LDL-r). This protein is now of high interest because antibodies which inhibit its effect...

Being retrieved, please wait for a moment...

International Cooperation:cnki.scholar@cnki.net, +86-10-82896619   Feedback:scholar@cnki.net

×